Optimisation of Disease Management in Patients With Epithelial Ovarian Cancer in France
试验速览
- 阶段
- 不适用
- 入组人数
- 376
- 试验地点
- 3
- 主要终点
- Incremental cost-effectiveness ratio expressed in cost per relapse-free year gained
研究概览
简要总结
No structured organization for ovarian first line management emerges in France. Management across France seems to depend on regional contexts.
Regions display no specific organization or delineate regional network for the ovarian cancer management or report centralized management revolving around referent centers. These different templates present a major problem in identifying differences, costs and benefit.
To deal with this issue the Investigators propose a health economic evaluation based on cost-effectiveness analyses, completed with a budget impact analysis. This study will investigate the cost-effective management of patients with initial ovarian cancer using databases representative of different parts of French territories.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Ovarian epithelial cancer initially diagnosed in 2012
- •Age > 18 years old
- •Residency in France (Rhône-Alpes region, District of Calvados and Cotes d'Or)
- •First-line ovarian epithelial cancer
排除标准
- •Relapsed ovarian epithelial cancer
- •Non epithelial ovarian cancer
结局指标
主要结局
Incremental cost-effectiveness ratio expressed in cost per relapse-free year gained
时间窗: 2 years after diagnosis
To perform a cost-effectiveness analysis in order to evaluate the most efficient organization for ovarian cancer in 1st line ot treatment
次要结局
- Relapse-free survival (RFS)(RFS will be assessed 2 years after diagnosis)
- Budget impact analysis(2 years after diagnosis)
- Incremental cost-effectiveness ratio expressed in cost per QALY(Quality-Adjusted Life Year) gained.(2 years after diagnosis)